SARS-CoV-2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study.

Journal Article

BACKGROUND: Children with SARS-CoV-2 infection typically have mild symptoms that do not require medical attention, leaving a gap in our understanding of the spectrum of illnesses that the virus causes in children. METHODS: We conducted a prospective cohort study of children and adolescents (<21 years of age) with a SARS-CoV-2-infected close contact. We collected nasopharyngeal or nasal swabs at enrollment and tested for SARS-CoV-2 using a real-time PCR assay. RESULTS: Of 382 children, 289 (76%) were SARS-CoV-2-infected. SARS-CoV-2-infected children were more likely to be Hispanic (p<0.0001), less likely to have a history of asthma (p=0.009), and more likely to have an infected sibling contact (p=0.0007) than uninfected children. Children ages 6-13 years were frequently asymptomatic (38%) and had respiratory symptoms less often than younger children (30% vs. 49%; p=0.008) or adolescents (30% vs. 59%; p<0.0001). Compared to children ages 6-13 years, adolescents more frequently reported influenza-like (61% vs. 39%; p=0.002), gastrointestinal (26% vs. 9%; p=0.003), and sensory symptoms (43% vs. 9%; p<0.0001), and had more prolonged illnesses [median (IQR) duration: 7 (4, 12) vs. 4 (3, 8) days; p=0.004]. Despite the age-related variability in symptoms, we found no differences in nasopharyngeal viral load by age or between symptomatic and asymptomatic children. CONCLUSIONS: Hispanic ethnicity and an infected sibling close contact are associated with increased SARS-CoV-2 infection risk among children, while a history of asthma is associated with decreased risk. Age-related differences in the clinical manifestations of SARS-CoV-2 infection must be considered when evaluating children for COVID-19 and in developing screening strategies for schools and childcare settings.

Full Text

Duke Authors

Cited Authors

  • Hurst, JH; Heston, SM; Chambers, HN; Cunningham, HM; Price, MJ; Suarez, L; Crew, CG; Bose, S; Aquino, JN; Carr, ST; Griffin, SM; Smith, SH; Jenkins, K; Pfeiffer, TS; Rodriguez, J; DeMarco, CT; De Naeyer, NA; Gurley, TC; Louzao, R; Cunningham, CK; Steinbach, WJ; Denny, TN; Lugo, DJ; Moody, MA; Permar, SR; Rotta, AT; Turner, NA; Walter, EB; Woods, CW; Kelly, MS

Published Date

  • September 1, 2020

Published In

  • Medrxiv

PubMed ID

  • 32908992

Pubmed Central ID

  • PMC7480040

Digital Object Identifier (DOI)

  • 10.1101/2020.08.18.20166835


  • eng

Conference Location

  • United States